These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans. Ellebedy AH; Krammer F; Li GM; Miller MS; Chiu C; Wrammert J; Chang CY; Davis CW; McCausland M; Elbein R; Edupuganti S; Spearman P; Andrews SF; Wilson PC; García-Sastre A; Mulligan MJ; Mehta AK; Palese P; Ahmed R Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13133-8. PubMed ID: 25157133 [TBL] [Abstract][Full Text] [Related]
8. Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody. Raymond DD; Bajic G; Ferdman J; Suphaphiphat P; Settembre EC; Moody MA; Schmidt AG; Harrison SC Proc Natl Acad Sci U S A; 2018 Jan; 115(1):168-173. PubMed ID: 29255041 [TBL] [Abstract][Full Text] [Related]
10. A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head. Benjamin E; Wang W; McAuliffe JM; Palmer-Hill FJ; Kallewaard NL; Chen Z; Suzich JA; Blair WS; Jin H; Zhu Q J Virol; 2014 Jun; 88(12):6743-50. PubMed ID: 24696468 [TBL] [Abstract][Full Text] [Related]
11. Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans. Nachbagauer R; Wohlbold TJ; Hirsh A; Hai R; Sjursen H; Palese P; Cox RJ; Krammer F J Virol; 2014 Nov; 88(22):13260-8. PubMed ID: 25210189 [TBL] [Abstract][Full Text] [Related]
12. Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies. Wang W; Song HS; Keller PW; Alvarado-Facundo E; Vassell R; Weiss CD J Virol; 2018 Jun; 92(12):. PubMed ID: 29593038 [TBL] [Abstract][Full Text] [Related]
13. Measuring influenza hemagglutinin (HA) stem-specific antibody-dependent cellular cytotoxicity (ADCC) in human sera using novel stabilized stem nanoparticle probes. Smatti MK; Nasrallah GK; Al Thani AA; Yassine HM Vaccine; 2020 Jan; 38(4):815-821. PubMed ID: 31735504 [TBL] [Abstract][Full Text] [Related]
14. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design. Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889 [TBL] [Abstract][Full Text] [Related]
15. First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes. Guthmiller JJ; Han J; Li L; Freyn AW; Liu STH; Stovicek O; Stamper CT; Dugan HL; Tepora ME; Utset HA; Bitar DJ; Hamel NJ; Changrob S; Zheng NY; Huang M; Krammer F; Nachbagauer R; Palese P; Ward AB; Wilson PC Sci Transl Med; 2021 Jun; 13(596):. PubMed ID: 34078743 [TBL] [Abstract][Full Text] [Related]
16. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Li GM; Chiu C; Wrammert J; McCausland M; Andrews SF; Zheng NY; Lee JH; Huang M; Qu X; Edupuganti S; Mulligan M; Das SR; Yewdell JW; Mehta AK; Wilson PC; Ahmed R Proc Natl Acad Sci U S A; 2012 Jun; 109(23):9047-52. PubMed ID: 22615367 [TBL] [Abstract][Full Text] [Related]
18. Identification of Linear Peptide Immunogens with Verified Broad-spectrum Immunogenicity from the Conserved Regions within the Hemagglutinin Stem Domain of H1N1 Influenza Virus. Li S; Qiao Y; Xu Y; Li P; Nie J; Zhao Q; Chai W; Shi Y; Kong W; Shan Y Immunol Invest; 2022 Feb; 51(2):411-424. PubMed ID: 33078652 [TBL] [Abstract][Full Text] [Related]